NYSEArca - Delayed Quote USD

Virtus LifeSci Biotech Products ETF (BBP)

52.07 +0.58 (+1.13%)
At close: April 25 at 11:35 AM EDT

Top 10 Holdings (27.28% of Total Assets)

SymbolCompany% Assets
TARS
Tarsus Pharmaceuticals, Inc. 3.65%
LXRX
Lexicon Pharmaceuticals, Inc. 3.54%
ADMA
ADMA Biologics, Inc. 3.13%
SWTX
SpringWorks Therapeutics, Inc. 2.72%
SRPT
Sarepta Therapeutics, Inc. 2.63%
ASND
Ascendis Pharma A/S 2.41%
AGIO
Agios Pharmaceuticals, Inc. 2.41%
MRNA
Moderna, Inc. 2.38%
KNSA
Kiniksa Pharmaceuticals, Ltd. 2.22%
NBIX
Neurocrine Biosciences, Inc. 2.18%

Sector Weightings

SectorBBP
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.18%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.25
Price/Sales 0.14
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

ETF Overview

Category Health
Fund Family Virtus
Net Assets 19.84M
YTD Daily Total Return -10.37%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers